Related Experiment Video
Updated: Feb 5, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
[Arterial hypertension and determinants in Venezuela]
Rodrigo J Mijares-Seminario1, Elena M Rincón-Osorio2, Luis Azpurua3
1RM: Ing. Civil. M. Sc. Gerencia Logística. Ph. D. Ciencias Políticas. Profesor del Departamento de Tecnología de Procesos Biológicos y Bioquímicos. Universidad Simón Bolívar, Sartenejas. Caracas, Venezuela. rmijares@usb.ve; mijaresrodrigo@gmail.com.
Objective:
To determine the prevalence and determinants of arterial hypertension in the Venezuelan population.
Methods:
A systematic review of the literature was performed in the PubMed and LILACS databases. The inclusion criteria were hypertension, Venezuela and risks. Articles published in any language were chosen, with no time limit.
Results:
Out of 90 articles found during the search, only 20 met the inclusion criteria. Most of the data come from studies conducted in the central region of the country. The prevalence of hypertension found in the rural area is 33 %, while it oscillates between 24 and 31 % in the urban area, and 2.5 % in children. The studies showed that modifiable determining factors include obesity and dyslipidemias. In turn, non-modifiable factors include family history, race and age.
Conclusions:
Data are insufficient to establish the prevalence of the disease in Venezuela and its determinants. It is recommended to encourage multicenter prevalence studies that cover the entire country. Studies should be regularly done over time (longitudinal studies) to describe the increase or not in prevalence.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension I: Introduction

